EQS-News: innoscripta: Successful Clusterix Product Demonstrations for Investors
|
EQS-News: innoscripta SE
/ Key word(s): Miscellaneous
innoscripta: Successful Clusterix Product Demonstrations for Investors
Tutzing, October 30, 2026 – innoscripta SE (ISIN: DE000A40QVM8) successfully presented its Clusterix platform live to investors over two consecutive investor days. Investors from the DACHLI region and Scandinavia, including TOP Vermögen AG and Principal Vermögensverwaltung AG, gained exclusive insights into the software’s functionality and capabilities. Particular interest focused on the systematic use of artificial intelligence to further develop the platform, as well as Clusterix’s significant potential for expansion into additional markets. The lively discussions also covered the planned expansion of the platform’s capabilities to encompass the management of the entire R&D process and the continuous enhancement of its functionalities. Through direct exchanges with the Management Board, investors also had the opportunity to explore the company’s next strategic steps to further expand its operating business. Feedback was consistently positive.
Roland Neuwirth, Fund Manager at Advisory Invest GmbH: “As a shareholder in innoscripta since the IPO, the investor day gave us valuable insights into how Clusterix operates and the complexity behind the platform. This behind-the-scenes look at the company clearly demonstrated the platform’s added value and further strengthened our confidence in the investment case. innoscripta’s growth rates speak for themselves, and management’s regular share purchases demonstrate its commitment to the company.”
About innoscripta innoscripta SE offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable.
Investor Relations Contact innoscripta SE Max Hunger ir@innoscripta.de
Press contact edicto GmbH Ralf Droz / Svenja Liebig +49 69 905505 56 innoscripta@edicto.de
30.10.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | innoscripta SE |
| Bahnhofstraße 17 | |
| 82327 Tutzing | |
| Germany | |
| Phone: | +4989255553509 |
| E-mail: | info@innoscripta.com |
| Internet: | https://www.innoscripta.com |
| ISIN: | DE000A40QVM8 |
| WKN: | A40QVM |
| Listed: | Regulated Unofficial Market in Frankfurt (Scale) |
| LEI Code: | 894500BA6B025ZEF0T83 |
| EQS News ID: | 2425830 |
| End of News | EQS News Service |
|
|
2425830 30.10.2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 8,46 | 19,83 | 27,27 | 39,37 | 64,71 | 103,41 | 145,00 | |
| EBITDA1,2 | 0,63 | 7,85 | 9,33 | 15,62 | 37,46 | 63,62 | 76,00 | |
| EBITDA-Margin3 | 7,47 | 39,58 | 34,21 | 39,68 | 57,89 | 61,52 | 52,41 | |
| EBIT1,4 | 0,48 | 7,73 | 9,18 | 15,47 | 37,28 | 63,42 | 85,00 | |
| EBIT-Margin5 | 5,72 | 7,73 | 9,18 | 39,29 | 57,61 | 61,33 | 58,62 | |
| Net Profit (Loss)1 | 0,29 | 4,99 | 6,10 | 10,27 | 25,09 | 42,61 | 58,00 | |
| Net-Margin6 | 3,48 | 25,15 | 22,35 | 26,09 | 38,77 | 41,20 | 40,00 | |
| Cashflow1,7 | 0,44 | 1,73 | 8,89 | 5,26 | 20,14 | 40,83 | 52,00 | |
| Earnings per share8 | 0,03 | 0,50 | 0,61 | 1,03 | 2,51 | 4,26 | 3,00 | |
| Dividend per share8 | 0,00 | 0,00 | 0,50 | 0,80 | 2,40 | 4,00 | 1,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Nexia
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Innoscripta | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A40QVM | DE000A40QVM8 | SE | 519,00 Mio € | 23.05.2025 | Kaufen | 8FWH4GVX+FJ |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 18,54 | 17,30 | 1,07 | 31,46 | 16,13 | 12,71 | 5,02 |
|
Dividend '2024 in € |
Dividend '2025 in € |
Dividend '2026e in € |
Div.-Yield '2026e in % |
| 2,40 | 4,00 | 1,00 | 1,93% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 21.04.2026 | 26.05.2026 | 25.08.2026 | 03.11.2025 | 25.02.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -25,42% | -29,02% | -42,52% | -54,71% | -56,75% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
